Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

BioMarin, Glyko Biomedical Ltd. deal

February 11, 2002 8:00 AM UTC

BMRN will acquire GBL, which owns 11.4 million shares (22%) of BMRN. Under the deal, BMRN will acquire all of GBL’s shares, retire the 11.4 million BMRN shares owned by GBL and issue 11.4 million new ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article